Alkem Laboratories Doubles Investment to Rs 1,036 Crore for Ujjain Plant

Synopsis: Alkem Laboratories has made a bold move. The pharmaceutical company nearly doubled its planned investment for a new manufacturing facility in Ujjain, Madhya Pradesh.

The company’s Board of Directors approved the decision on Wednesday. Alkem raised its investment cap from Rs 533 crore to Rs 1,036 crore. Shares of Alkem Laboratories traded on the BSE and NSE amid this announcement. The stock drew investor attention following the disclosure of the expanded capital commitment.

A Plant Already in the Works

Alkem first announced the Ujjain project on March 18, 2026. The company received an allotment letter from DMIC Vikram Udyogpuri Limited on the same date. The letter confirmed the allotment of around 30 acres of land. The land sits in Phase-2 of the DMIC Vikram Udyogpuri Industrial Area in Ujjain. At that time, the Board had approved an initial investment of up to Rs 533 crore. The company planned to invest the amount in phases.

Alkem Laboratories Limited’s stock, with a market capitalisation of Rs. 63,022 crores, rose Rs. 5,276.50, up 0.61 percent from its previous closing price of Rs. 5,244.50. Furthermore, the stock over the past year has given a negative return of 7.84 percent.

Why the Sudden Increase?

The latest board decision nearly doubles the original budget. Alkem will now invest up to Rs 1,036 crore in a phased manner. The expanded funds will go toward setting up the greenfield formulations manufacturing facility. A greenfield project means the company builds the plant from scratch on unused land. Therefore, the larger investment signals a bigger facility than first planned. Alkem has not yet disclosed a timeline for completion.

What This Means for Alkem

Madhya Pradesh is emerging as a key hub for pharmaceutical manufacturing in India. Alkem’s decision to invest over Rs 1,000 crore shows strong confidence in this region. Furthermore, the move points to the company’s plans to expand its production capacity.

Formulations manufacturing is a core part of Alkem’s business. The company produces medicines that are sold across India and in international markets. A new, large-scale plant in Ujjain could, as a result, boost output significantly in the coming years.

What Comes Next

Alkem will build the facility in phases. This means the full Rs 1,036 crore will not be spent all at once. Instead, the company will release funds in stages as construction progresses.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Alkem Laboratories Doubles Investment to Rs 1,036 Crore for Ujjain Plant appeared first on Trade Brains.